Stefan Borgwardt

Prof. Stefan Borgwardt

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in JAMA Psychiatry
Verified
Journal Article
Closed access
PDF file
PFPaolo Fusar-Poli
Paolo Fusar-Poli
SBStefan Borgwardt
Stefan Borgwardt
ABAndreas Bechdolf
Andreas Bechdolf
JAJean Addington
Jean Addington
ARAnita Riecher-Rössler
Anita Riecher-Rössler
AYAlison Yung
Alison Yung
ContextDuring the past 2 decades, a major transition in the clinical characterization of psychotic disorders has occurred. The construct of a clinical high-risk (HR) state for psychosis has evolved to capture the prepsychotic phase, describing people presenting with potentially prodromal symptoms. The importance of this HR state has been increasingly recognized to such an extent that a new syndrome is being considered as a diagnostic category in the DSM-5.ObjectiveTo reframe the HR state in a comprehensive state-of-the-art review on the progress that has been made while also recognizing the challenges that remain.Data SourcesAvailable HR research of the past 20 years from PubMed, books, meetings, abstracts, and international conferences.Study Selection and Data ExtractionCritical review of HR studies addressing historical development, inclusion criteria, epidemiologic research, transition criteria, outcomes, clinical and functional characteristics, neurocognition, neuroimaging, predictors of psychosis development, treatment trials, socioeconomic aspects, nosography, and future challenges in the field.Data SynthesisRelevant articles retrieved in the literature search were discussed by a large group of leading worldwide experts in the field. The core results are presented after consensus and are summarized in illustrative tables and figures.ConclusionsThe relatively new field of HR research in psychosis is exciting. It has the potential to shed light on the development of major psychotic disorders and to alter their course. It also provides a rationale for service provision to those in need of help who could not previously access it and the possibility of changing trajectories for those with vulnerability to psychotic illnesses.

1 March 2012 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
PFPaolo Fusar-Poli
Paolo Fusar-Poli
IBIlaria Bonoldi
Ilaria Bonoldi
AYAlison R. Yung
Alison R. Yung
SBStefan Borgwardt
Stefan Borgwardt
MKMatthew J. Kempton
Matthew J. Kempton
PMPhilip McGuire
Philip McGuire
Although prodromal symptoms of psychosis have long been recognized,2 the clinical management of psychotic disorders conventionally begins at the first episode of frank psychosis, and, until recently, the period immediately preceding the first episode received relatively little attention. For the past 15 years, there has been increasing academic and clinical interest in people presenting with potentially prodromal symptoms.3 This clinical syndrome has been termed an at risk mental state,4 and operationalized criteria—the ultra high risk (UHR)5 or clinical high risk (HR)6 criteria—have been developed to identify the syndrome.4 The criteria apply to young help-seeking patients and require 1 of 3 presentations:“attenuated” psychotic symptoms, full-blown psychotic symptoms that are brief and self-limiting, or a significant decrease in functioning in the context of a genetic risk for schizophrenia.7 Additional prodromal criteria emerging from the basic symptoms (BS) literature8 include subjective disturbances of cognitive processing and the perception of the self and the world.9 Belonging to one of these prodromal groups, which we hereafter term the clinical high risk syndrome, is associated with impairments in neuropsychologic performance10 and alterations in the structure11-13 (for meta-analyses, see Fusar-Poli et al14,15), function16-18 (for meta-analyses, see Smieskova et al19 and Fusar-Poli et al20), connectivity,21 and neurochemistry22-24 of the brain.

1 November 2018 in Biological Psychiatry
Verified
Journal Article
Open access
TETheo G.M. van Erp
Theo G.M. van Erp
EWEsther Walton
Esther Walton
DHDerrek P. Hibar
Derrek P. Hibar
LSLianne Schmaal
Lianne Schmaal
WJWenhao Jiang
Wenhao Jiang
FOFunda Orhan
Funda Orhan
The profile of cortical neuroanatomical abnormalities in schizophrenia is not fully understood, despite hundreds of published structural brain imaging studies. This study presents the first meta-analysis of cortical thickness and surface area abnormalities in schizophrenia conducted by the ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis) Schizophrenia Working Group. The study included data from 4474 individuals with schizophrenia (mean age, 32.3 years; range, 11-78 years; 66% male) and 5098 healthy volunteers (mean age, 32.8 years; range, 10-87 years; 53% male) assessed with standardized methods at 39 centers worldwide. Compared with healthy volunteers, individuals with schizophrenia have widespread thinner cortex (left/right hemisphere: Cohen's d = -0.530/-0.516) and smaller surface area (left/right hemisphere: Cohen's d = -0.251/-0.254), with the largest effect sizes for both in frontal and temporal lobe regions. Regional group differences in cortical thickness remained significant when statistically controlling for global cortical thickness, suggesting regional specificity. In contrast, effects for cortical surface area appear global. Case-control, negative, cortical thickness effect sizes were two to three times larger in individuals receiving antipsychotic medication relative to unmedicated individuals. Negative correlations between age and bilateral temporal pole thickness were stronger in individuals with schizophrenia than in healthy volunteers. Regional cortical thickness showed significant negative correlations with normalized medication dose, symptom severity, and duration of illness and positive correlations with age at onset. The findings indicate that the ENIGMA meta-analysis approach can achieve robust findings in clinical neuroscience studies; also, medication effects should be taken into account in future genetic association studies of cortical thickness in schizophrenia.

24 September 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
K(Karolinska Schizophrenia Project (KaSP)
Karolinska Schizophrenia Project (KaSP)
TKTobias Kaufmann
Tobias Kaufmann
DMDennis van der Meer
Dennis van der Meer
NDNhat Trung Doan
Nhat Trung Doan
ESEmanuel Schwarz
Emanuel Schwarz
LWLars T. Westlye
Lars T. Westlye

1 June 2012 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
PFPaolo Fusar-Poli
Paolo Fusar-Poli
GDGiacomo Deste
Giacomo Deste
RSRenata Smieskova
Renata Smieskova
Stefano BarlatiStefano Barlati
Stefano Barlati
AYAlison R. Yung
Alison R. Yung
SBStefan Borgwardt
Stefan Borgwardt
Neurocognitive deficits have been identified as a robust feature of schizophrenia since its earliest descriptions1,2 and are a central manifestation of the pathophysiology of the disorder.3 The most consistent impairments are in the domains of attention, memory, and executive function and are already evident at the time of the first episode of illness.4 Impairments are also observed in social cognition,5,6 defined as the mental processes by which humans interpret and respond to others' behavior.7 The extent to which these cognitive deficits progress over the course of the disorder is still debated,8 with some studies suggesting that there is no change over time but others indicating that deficits get progressively worse.9 These inconsistent findings may be explained by the confounding effects of antipsychotic medications and the other features of the disorder, such as persistent psychotic symptoms, institutionalization, and poor physical health.

18 November 2009 in Neuropsychopharmacology
Verified
Journal Article
Closed access
SBSagnik Bhattacharyya
Sagnik Bhattacharyya
PMPaul D Morrison
Paul D Morrison
PFPaolo Fusar-Poli
Paolo Fusar-Poli
RMRocio Martin-Santos
Rocio Martin-Santos
SBStefan Borgwardt
Stefan Borgwardt
PMPhilip K McGuire
Philip K McGuire